UroGen Pharma Ltd. (URGN) stock
URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.79−0.08 (-0.27%)
Close on Nov 18, 2026Market cap $1.46BP/E –Yield –
UroGen Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
UroGen Pharma's market cap was $1.28B on Nov 11, 2026, against $1.35B a year earlier. Over the last 5 years it ranged from $120.67M to $2.11B, with a median of $491.58M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.28B | +16.4% |
| 2025 | Dec 31, 2025 | $1.10B | +143.8% |
| 2024 | Dec 31, 2024 | $449.33M | -29.0% |
| 2023 | Dec 29, 2023 | $633.00M | +210.1% |
| 2022 | Dec 30, 2022 | $204.11M | -4.2% |
| 2021 | Dec 31, 2021 | $213.07M | -46.4% |
| 2020 | Dec 31, 2020 | $397.73M | -43.1% |
| 2019 | Dec 31, 2019 | $698.91M | +0.8% |
| 2018 | Dec 31, 2018 | $693.36M | +708.1% |
| 2017 | Dec 29, 2017 | $85.80M | – |
See a number that looks wrong?